Stress and Cortisol:
The Plague of the 21st Century
|
Anti-Cortisol Supplements
Fortunately modern scientific research, drawing on ancient systems
of medicine, has provided us with supplements that reduce excess cortisol and
its many toxic effects. Relora is a proprietary blend of a patented extract from
Magnolia officinalis bark and a patent-pending extract from Phellodendron
amurense bark, developed by Next Pharmaceuticals.
For centuries Japanese Kampo medicine has used Magnolia bark in
herbal remedies such as Saiboku-to to treat clinical depression, anxiety
neurosis, insomnia, anxiety, hysteria, stroke and gastrointestinal complaints
(all potentially caused by cortisol excess). Two Magnolia bark compounds,
magnolol and honokiol, have been identified as the anxiolytic (anti-anxiety)
agents in Saiboku-to. Unlike benzodiazepines such as Valium
they do not cause CNS depression, excessive muscle relaxation, amnesia or
physical dependence. Relora is standardized to a certain level of magnolol and
honokiol. In an animal screening model, the two extracts used in Relora
demonstrated anxiolytic activity without sedation.
An acute toxicity study using 5,000 mg/kg revealed no significant
side effects after 14 days observation. An LD50 (the lethal dose for 50 percent
of the test animals) was not able to be established because of the extreme
non-toxicity of Relora.
Relora: Human Trials
Fifty stressed people were given 200 mg Relora three times per day
for two weeks. Post-trial analysis revealed that 82 percent found Relora
effective in controlling stress-induced symptoms, such as depression, anxiety,
irritability, emotional ups and downs, concentration difficulties and
restlessness. Seventy-eight percent reported increased relaxation, while 74
percent had more restful sleep. No significant side effects were reported,
although 24 percent reported some temporary initial drowsiness, and 6 percent
reported mild and transient GI upset.
In a second clinical trial, 49 stressed subjects who suffered from
stress-induced overeating were given a two-to-three-times per day dose of Relora
for two weeks. There was a 76 percent decline in high fat/sugar/salt snack
eating. Eighty-four percent reported more restful sleep. The vast majority noted
that Relora helped them relax without drowsiness.
In a third trial 12 stressed subjects took Relora for two weeks.
Salivary DHEA and cortisol measurements were taken. Morning salivary cortisol
levels (when cortisol levels are normally highest) dropped 37 percent, while
DHEA levels rose 227 percent. Previously abnormal cortisol/DHEA levels returned
to normal in all subjects by the study's end.
Sensoril
Sensoril is a patented proprietary extract of roots and leaves from
Withania somnifera Dunn, known as Ashwagandha in Ayurvedic medicine. Developed
by researcher Dr. S. Ghosal, who has published many scientific papers on the
anti-stress action of various Ashwagandha compounds, Sensoril is standardized to
contain the proper amounts of glycowithanolides, Withaferin-A, and
oligosaccarides that research has shown to promote optimal anti-stress activity.
Sensoril is a carefully balanced formulation of the key compounds
that provide Ashwagandha's immunomodulating and
anti-stress activity. By optimizing the ratio of oligosaccharides to
polysaccharides, Dr. Ghosal's formulation protects the
withanolides from digestive inactivation and enhances their absorption.
Ashwagandha has been used in Ayurvedic medicine for many centuries to promote
resistance to stress, and to promote health and longevity by increasing
resistance to disease, slowing the aging process and revitalizing the body in
debilitating conditions. It has also been reported to enhance mental function
and memory.
Cortisol Control Formula: Relora Plus Sensoril
Given the excellent safety profile of the active ingredients in
Relora and Sensoril, their use for centuries in Oriental medicine and their
modern scientific validation, it makes sense to combine them to create a potent
anti-stress supplement known as Cortisol Control Formula. Each Cortisol Control
Formula capsule contains 250 mg Relora and 75 mg Sensoril. The recommended dose
is one capsule three times per day. Cortisol Control should not be combined with
alcohol. It should not be taken with prescription psychiatric drugs, such as
Valium or other benzodiazepines, without physician approval. Cortisol Control
is not intended for use by children under 18, or pregnant or lactating women.
Relora is already a widely used, popular stress-management
supplement. Naturopathic physician James LaValle has reported excellent results
with its use in his practice. The new combination of Relora and Sensoril should
prove even more effective in helping to alleviate stress overload, the scourge
of our modern 24/7 hyper-drive world.
Highly recommended
source of nutrients and supplements.
References:
1. Selye, H. The evolution of the stress concept.
Amer Sci 1973, 61: 692-99.
2. Carpenter, W. et al. Cortisol s effects on human mental
functioning. J Clin Psychopharmacol 1982, 2: 91-101.
3. Hardman, J. and Limbird, L., eds. Goodman and Gilman s The
Pharmacological Basis of Therapeutics. NYC: McGraw-Hill; 1996:1464.
4. Guyton, A. and Hall, J. Textbook of Medical Physiology.
Philadelphia: W.B. Sanders; 2000: 869-83.
5. Sapse, A. Stress, cortisol, interferon and stress
diseases. Med Hypoth 1984, 13: 31-44.
6. Starkman, M. and Schteingart, D. Neuropsychiatric
manifestations of patients with Cushing s syndrome. J Clin
Psych 1981, 141: 215-19.
7. Epel, E. et al. Stress may add bite to appetite in women: a
laboratory study of stress-induced cortisol and eating behavior.
Psychoneuroendocrinol 2001, 26: 37-49.
8. Maruyama, Y. and Kuribara, H. Overview of the
pharmacological features of Honokiol. CNS Drug Rev 2000, 6:
35-44.
9. Sufka, K. et al. Anxiolytic properties of botanical
extracts in the chick social separation-stress procedure
Psychopharmacol 2001, 153: 219-24
10. LaValle, J. and Hawkins, E. Relora The Natural Breakthrough to
Losing Stress-Related Fat and Wrinkles. North Bergen, NJ: Basic
Health Publications; 2003: 16.
11. Bhattacharya, S. et al. Anti-stress activity of
sitoindosides VII and VIII, new acylsterylglucosides from Withania
somnifera. Phytother Res 1987, 1: 32-37.
12. Ramarao, P. et al. Effects of glycowithanolides from
Withania somnifera on morphine-induced inhibition of intestinal
motility and tolerance to analgesia in mice. Phytother Res
1995, 9: 66-68.
13. Ghosal, S. et al. Immunomodulatory and CNS effects of
sitoindosides IX and X, two new glycowithanolides from Withania
somnifera. Phytother Res 1989, 3: 201-06.
14. Bhattacharya, S. et al. Antioxidant activity of
glycowithanolides from Withania somnifera. Ind J Exper Biol
1997, 35: 236-39.
15. Naidu, P. et al. Effect of Withania somnifera root extract
on haloperidol-induced orofacial dyskinesia: possible mechanisms of
action.. J Medicinal Food 2003, 6: 107-14.
16. LaValle, J. and Yale, S. Cracking the Metabolic Code. North
Bergen, NJ: Basic Publications; 2004: 126.
Binaural Beat Brainwave Entrainment Audio Technology | Advanced Human Biochemical Enhancement
This site is featured in the Infinite Play the Movie
Home |
About Us |
Contact Us |
Translation Services |
Request Or Comment |
Products | Services |
Projects
Copyright Intelegen Inc.
1995 - 2010 All
rights reserved
